Related Experiment Videos
Imaging methods in gene therapy of cancer
1Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Dept. of Nuclear Medicine, University of Heidelberg, Germany. Uwe_Haberkorn@med.uni-heidelberg.de
Abstract:
Clinical gene therapy needs non invasive tools to evaluate the efficiency of gene transfer. This includes the evaluation of infection efficiency as well as the verification of successful gene transfer in terms of gene transcription. These informations can be used for therapy planning, follow up studies in treated tumors and as an indicator of prognosis. Therapy planning is performed by the assessment of gene expression for example using radiolabeled specific substrates to determine the activity of suicide enzymes as the Herpes Simplex Virus thymidine kinase or cytosine deaminase. Furthermore, other in vivo reporter genes as receptors, antigens or transport proteins may be used in bicistronic vector systems for the evaluation of gene transduction and expression. This is done using radiolabeled ligands, antigens or substrates. Follow up studies with magnetic resonance imaging, single photon emission tomography or positron emission tomography may be done to evaluate early or late effects of gene therapy on tumor volume, metabolism or proliferation. Finally, enhancement of radioactive isotope accumulation in tumors by transfer of the appropriate genes may be used for the treatment of malignant tumors.
Insights
Non-invasive imaging tools are crucial for assessing gene therapy success. These methods evaluate gene transfer efficiency, transcription, and tumor response, aiding in treatment planning and prognosis. Keywords: gene therapy, non-invasive imaging, gene transfer, tumor treatment.
Area of Science:
- Molecular Biology
- Medical Imaging
- Oncology
Background:
- Clinical gene therapy requires non-invasive methods to assess gene transfer efficiency and transcription.
- Current methods are essential for therapy planning, tumor follow-up, and prognostic evaluation.
Purpose of the Study:
- To review non-invasive tools for evaluating gene transfer and expression in clinical gene therapy.
- To highlight the role of imaging in assessing gene therapy outcomes and potential therapeutic applications.
Main Methods:
- Utilizing radiolabeled substrates to assess suicide enzyme activity (e.g., Herpes Simplex Virus thymidine kinase, cytosine deaminase).
- Employing in vivo reporter genes (receptors, antigens, transport proteins) with bicistronic vectors for transduction and expression evaluation.
- Leveraging advanced imaging techniques like magnetic resonance imaging (MRI), single photon emission tomography (SPECT), and positron emission tomography (PET) for monitoring tumor response.
Main Results:
- Non-invasive imaging allows for precise assessment of gene transfer and transcriptional activity.
- Reporter gene systems enable real-time monitoring of gene expression and transduction efficiency.
- Imaging modalities can track therapeutic effects on tumor volume, metabolism, and proliferation.
Conclusions:
- Non-invasive imaging tools are vital for optimizing gene therapy strategies.
- Gene transfer can be harnessed for targeted tumor treatment through enhanced radioactive isotope accumulation.
- These advancements facilitate personalized medicine approaches in gene therapy and oncology.